F. Lacheretz

514 total citations
13 papers, 397 citations indexed

About

F. Lacheretz is a scholar working on Oncology, Orthopedics and Sports Medicine and Small Animals. According to data from OpenAlex, F. Lacheretz has authored 13 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Orthopedics and Sports Medicine and 2 papers in Small Animals. Recurrent topics in F. Lacheretz's work include Bone health and treatments (3 papers), Bone health and osteoporosis research (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). F. Lacheretz is often cited by papers focused on Bone health and treatments (3 papers), Bone health and osteoporosis research (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). F. Lacheretz collaborates with scholars based in France, Belgium and Japan. F. Lacheretz's co-authors include A. Barbier, Philippe Soubrié, Jean Marc Herbert, Philip Janiak, M. Arnone, Mohammed Bensaïd, Jean Pierre Maffrand, Florence Oury-Donat, Pietro Marini and Magali Gary‐Bobo and has published in prestigious journals such as Hepatology, Journal of Bone and Mineral Research and Thrombosis and Haemostasis.

In The Last Decade

F. Lacheretz

13 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Lacheretz France 6 166 138 102 70 63 13 397
Bartłomiej Kisiel Poland 12 35 0.2× 67 0.5× 29 0.3× 104 1.5× 34 0.5× 41 491
B. Zimmerman United States 6 45 0.3× 137 1.0× 27 0.3× 45 0.6× 286 4.5× 12 554
E.-Y. Liao China 8 26 0.2× 29 0.2× 165 1.6× 121 1.7× 100 1.6× 9 368
Sirish Maddali United States 10 57 0.3× 20 0.1× 19 0.2× 65 0.9× 21 0.3× 12 395
Patrick Y.P. Kao Hong Kong 12 163 1.0× 11 0.1× 20 0.2× 96 1.4× 65 1.0× 19 404
Shigeto Maekawa Japan 13 49 0.3× 12 0.1× 57 0.6× 164 2.3× 29 0.5× 27 581
Nicholas Russell Australia 10 16 0.1× 144 1.0× 44 0.4× 90 1.3× 22 0.3× 23 414
Jennifer L. Kirby United States 14 29 0.2× 87 0.6× 72 0.7× 113 1.6× 102 1.6× 24 529
Konstantinos I. Papadopoulos Thailand 13 41 0.2× 55 0.4× 48 0.5× 73 1.0× 75 1.2× 31 415
Wen Geng China 7 141 0.8× 10 0.1× 36 0.4× 144 2.1× 60 1.0× 14 460

Countries citing papers authored by F. Lacheretz

Since Specialization
Citations

This map shows the geographic impact of F. Lacheretz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Lacheretz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Lacheretz more than expected).

Fields of papers citing papers by F. Lacheretz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Lacheretz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Lacheretz. The network helps show where F. Lacheretz may publish in the future.

Co-authorship network of co-authors of F. Lacheretz

This figure shows the co-authorship network connecting the top 25 collaborators of F. Lacheretz. A scholar is included among the top collaborators of F. Lacheretz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Lacheretz. F. Lacheretz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gary‐Bobo, Magali, Philip Janiak, Pietro Marini, et al.. (2007). Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology. 46(1). 122–129. 243 indexed citations
2.
Lacheretz, F., et al.. (2000). Effect of SR121463, a Selective Non-Peptide Vasopressin V 2 Receptor Antagonist, in a Rabbit Model of Ocular Hypertension. Journal of Ocular Pharmacology and Therapeutics. 16(3). 203–216. 17 indexed citations
3.
Barbier, A., Catherine Martel, M.C. de Vernejoul, et al.. (1999). The visualization and evaluation of bone architecture in the rat using three-dimensional X-Ray microcomputed tomography. Journal of Bone and Mineral Metabolism. 17(1). 37–44. 59 indexed citations
4.
Carayon, P, et al.. (1999). Contact allergens, but not irritants, alter receptor-mediated endocytosis by human epidermal Langerhans cells. British Journal of Dermatology. 140(2). 200–209. 18 indexed citations
5.
Verschuère, Bruno, et al.. (1998). Observations on acute gastric dilatation in nonhuman primates. Toxicology Letters. 95. 175–175. 5 indexed citations
6.
Beck, Lyle V., et al.. (1998). Clinical biochemistry, hematology, and hormone samples in the rat under isoflurane anesthesia. Toxicology Letters. 95. 191–191. 1 indexed citations
7.
Carayon, P, et al.. (1994). Internalization of surface HLA-DR molecules by human epidermal Langerhans cells: analysis by flow cytometry and confocal microscopy. Cell Biology and Toxicology. 10(5-6). 367–373. 1 indexed citations
8.
Geusens, Piet, Jo Nijs, Georges Van der Perre, et al.. (1992). Longitudinal effect of tiludronate on bone mineral density, resonant frequency, and strength in monkeys. Journal of Bone and Mineral Research. 7(6). 599–609. 39 indexed citations
9.
Barbier, A., P. Geusens, F. Lacheretz, et al.. (1992). Interest of biomechanical analysis in the experimental bone quality evaluation: The study of tiludronate as an example. Bone and Mineral. 17. 167–167. 1 indexed citations
10.
Doutremepuich, Jean-Daniel, et al.. (1991). Effect of Endotelon (procyanidolic oligomers) on experimental acute lymphedema of the rat hindlimb.. PubMed. 24(3). 135–9. 3 indexed citations
11.
Siè, Piérre, J. Lansen, F. Lacheretz, Bruno Verschuère, & B Boneu. (1986). Comparative Turn-Over of Heparin Cofactor II and Antithrombin III in Baboons Influence of Heparin and Pentosan Polysulfate Administration. Thrombosis and Haemostasis. 56(3). 302–307. 8 indexed citations
12.
Vic, P., et al.. (1985). Intestinal Pathology in the Dog Induced by Sublethal Doses of Amiodarone. Archives of toxicology. Supplement. 8. 104–109. 1 indexed citations
13.
Mazué, Guy, et al.. (1984). Toxicological studies of ticlopidine in laboratory animals.. PubMed. 15. 126–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026